Context Therapeutics Inc. Common Stock
$0.38
$0.01 (+4.01%)
$0.36Day Range$0.39
Key Statistics
Market Cap
$34.82M
Shares Outstanding
91.9M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Oct 20, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$0.37
Day High
$0.39
Day Low
$0.36
Volume
2.13M
VWAP
$0.38
Prev Close
$0.36
Transactions
--
Acc. Volume
--
About Context Therapeutics Inc. Common Stock
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
PHARMACEUTICAL PREPARATIONSSIC 283415 employees2001 MARKET STREET, PHILADELPHIA, PA, 19103267-225-7416IPO Oct 20, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001842952
- Composite FIGI
- BBG011YW6H86
- Share Class FIGI
- BBG011YW6J46
- Ticker Root
- CNTX
- SIC Code
- 2834
About Context Therapeutics Inc. Common Stock (CNTX) Stock
Context Therapeutics Inc. Common Stock (CNTX) closed the 2026-09-16 session at $0.38, up 4.01% versus the previous close (+0.01). The stock opened at $0.37 and traded between $0.36 and $0.39 during that session. Session trading volume was 2.1M shares. The volume-weighted average price (VWAP) is $0.38.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
Context Therapeutics Inc. Common Stock has a market capitalization of $34.8 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. CNTX is listed on the XNAS exchange. The company employs approximately 15 people. Context Therapeutics Inc. Common Stock is headquartered in PHILADELPHIA, PA. The recorded listing date is 2021-10-20.
On this page you can find market CNTX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.